n(6)-carboxymethyllysine has been researched along with Non-alcoholic Fatty Liver Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buch, A; Erez, N; Halpern, Z; Kolodkin-Gal, I; Salomone, F; Shibolet, O; Webb, M; Yeshua, H; Zelber-Sagi, S | 1 |
| Bloemen, JG; Buurman, WA; Dejong, CH; Driessen, A; Gaens, KH; Greve, JW; Hofker, MH; Niessen, PM; Rensen, SS; Schalkwijk, CG; Stehouwer, CD; Wolfs, MG | 1 |
2 other study(ies) available for n(6)-carboxymethyllysine and Non-alcoholic Fatty Liver Disease
| Article | Year |
|---|---|
Protective role of soluble receptor for advanced glycation end-products in patients with non-alcoholic fatty liver disease.
Topics: Adult; Biomarkers; Case-Control Studies; Female; Humans; Israel; Life Style; Logistic Models; Lysine; Male; Middle Aged; Multivariate Analysis; Non-alcoholic Fatty Liver Disease; Receptor for Advanced Glycation End Products; Solubility; Surveys and Questionnaires | 2017 |
Endogenous formation of Nε-(carboxymethyl)lysine is increased in fatty livers and induces inflammatory markers in an in vitro model of hepatic steatosis.
Topics: Aged; Biomarkers; Biopsy; Cytokines; Enzyme Inhibitors; Fatty Liver; Female; Gene Expression; Guanidines; Hep G2 Cells; Hepatocytes; Humans; In Vitro Techniques; Liver; Lysine; Male; Middle Aged; Non-alcoholic Fatty Liver Disease; Obesity; Pyridoxamine; Vitamin B Complex | 2012 |